Management of Mucositis with the Use of Leucovorin As Adjunct to Pralatrexate in Treatment of Peripheral T-Cell Lymphomas (PTCL) - Results from a Prospective Multicenter Phase 2 Clinical Trial

被引：3
|
作者：
Shustov, Andrei R. [1 ,2 ]
Shinohara, Michi M. [3 ]
Dakhil, Shaker R. [4 ]
Bhat, Gajanan [5 ]
Zain, Jasmine M. [6 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Washington, Div Hematol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Dermatol, Seattle, WA 98195 USA
[4] Canc Ctr Kansas, Wichita, KS USA
[5] Spectrum Pharmaceut Inc, Irvine, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2910
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of leucovorin on mucositis and skin reactions in pts with peripheral t-cell lymphoma (PTCL) and cutaneous t-cell lymphoma (CTCL) treated with pralatrexate.
    Foss, Francine M.
    Parker, Terri L.
    Li, Anlong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Safety and Management of Pralatrexate Treatment in Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL).
    Pinter-Brown, Lauren
    Horwitz, Steven M.
    Pro, Barbara
    Zinzani, Pier Luigi
    Gisselbrecht, Christian
    Cortelli, Barbara MacGregor
    Fruchtman, Steven
    O'Connor, Owen A.
    BLOOD, 2009, 114 (22) : 668 - 668
  • [3] PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
    O'Connor, O.
    Pro, B.
    Pinter-Brown, L.
    Popplewell, L.
    Bartlett, N.
    Lechowicz, M.
    Savage, K.
    Coiffier, B.
    Saunders, M.
    Horwitz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.
    Buckstein, Rena
    Crump, Michael
    Fraser, Graeme A.
    Cheung, Matthew C.
    Piliotis, Eugenia
    Imrie, Kevin
    Kukreti, Vishal
    Kuruvilla, John
    Meyer, Ralph M.
    Windsor, Jolanta
    Pond, Gregory Russell
    Pritchard, Kathleen I.
    Levine, Mark Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
    Maeda, Yoshinobu
    Tobinai, Kensei
    Nagai, Hirokazu
    Nakane, Takahiko
    Shimoyama, Tatsu
    Nakazato, Tomonori
    Sakai, Rika
    Ishikawa, Takayuki
    Izutsu, Koji
    Ueda, Ryuzo
    BLOOD, 2016, 128 (22)
  • [6] Attempt to optimize the management of peripheral T-cell lymphomas in the front line: the moderate results of the COEP associated with pralatrexate
    Philippe, Laure
    HEMATOLOGIE, 2016, 22 (02): : 94 - 95
  • [7] Phase I/II trial of pralatrexate in patients with chemotherapy-resistant precursor and peripheral T-cell lymphomas
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05): : 338 - 339
  • [8] Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL)
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Craig, Michael
    Geskin, Larisa
    Hutchins, Laura
    Joske, David
    Kirschbaum, Mark
    Leonard, John P.
    Prince, Miles
    Reeder, Craig B.
    Jaffe, Elaine
    Bates, Susan
    BLOOD, 2008, 112 (11) : 555 - 556
  • [9] Plitidepsin Is Active in Peripheral T-Cell Lymphoma (PTCL): A Subset Analysis from An Ongoing Multicenter Phase II Trial
    Ferme, Christophe
    Mateos, Maria Victoria
    Szyldergemajn, Sergio
    Zucca, Emanuele
    Espinoza, Jose
    Briones, Javier
    Morschhauser, Franck
    Gisselbrecht, Christian
    Ribrag, Vincent
    BLOOD, 2008, 112 (11) : 555 - 555
  • [10] Final Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Joske, David
    Kirschbaum, Mark
    Lewis, Ian D.
    Prince, Miles
    Smith, Sonali
    Jaffe, Elaine S.
    Bates, Susan
    BLOOD, 2009, 114 (22) : 661 - 662
12345